Crimean‐Congo hemorrhagic fever virus delays activation of the innate immune response

As a first line of defence against virus infection, mammalian cells elicit an innate immune response, characterized by secretion of type I interferons and the up‐regulation of interferon stimulated genes. Many viruses down‐regulate the innate immune responses in order to enhance their virulence. Crimean‐Congo hemorrhagic fever virus (CCHFV), a Nairovirus of the family Bunyaviridae is the causative agent of severe hemorrhagic fever in humans with high mortality. Knowledge regarding the innate immune response against CCHFV is most limited. Interestingly, in this study it is shown that replicating CCHFV delays substantially the IFN response, possibly by interfering with the activation pathway of IRF‐3. In addition, it is demonstrated that CCHFV replication is almost insensitive to subsequent treatment with interferon‐α. Once the virus is replicating, virus replication is more or less insensitive to the antiviral effects induced by the interferon. By using an interferon bioassay, it is shown that infected cells secrete interferon relatively late after infection, that is, 48 hr post‐infection. In summary, the results suggest the presence of a virulence factor encoded by CCHFV that delays the host defence in order to allow rapid viral spread in the host. J. Med. Virol. 80:1397–1404, 2008. © 2008 Wiley‐Liss, Inc.

[1]  Shannon L. Taylor,et al.  Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune Responses , 2007, Cell Host & Microbe.

[2]  A. Pichlmair,et al.  Innate recognition of viruses. , 2007, Immunity.

[3]  M. Yoneyama,et al.  Function of RIG-I-like Receptors in Antiviral Innate Immunity* , 2007, Journal of Biological Chemistry.

[4]  J. Klingström,et al.  Lambda Interferon (IFN-λ) in Serum Is Decreased in Hantavirus-Infected Patients, and In Vitro-Established Infection Is Insensitive to Treatment with All IFNs and Inhibits IFN-γ-Induced Nitric Oxide Production , 2007, Journal of Virology.

[5]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[6]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[7]  F. Weber,et al.  Double-Stranded RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable Amounts by Negative-Strand RNA Viruses , 2006, Journal of Virology.

[8]  Christine A. Biron,et al.  Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente , 2006, Science.

[9]  Ö. Ergönül.  Crimean-Congo haemorrhagic fever , 2006, The Lancet Infectious Diseases.

[10]  Å. Lundkvist,et al.  Type I interferon inhibits Crimean‐Congo hemorrhagic fever virus in human target cells , 2006, Journal of medical virology.

[11]  Shizuo Akira,et al.  Innate immune recognition of viral infection , 2006, Nature Immunology.

[12]  G. Kochs,et al.  The interferon response circuit: Induction and suppression by pathogenic viruses , 2005, Virology.

[13]  S. Finke,et al.  Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.

[14]  M. Barro,et al.  Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Andreas Pichlmair,et al.  Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.

[16]  G. Kochs,et al.  Thogoto virus ML protein suppresses IRF3 function. , 2005, Virology.

[17]  S. Goodbourn,et al.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Chris A Whitehouse,et al.  Crimean-Congo hemorrhagic fever. , 2004, Antiviral research.

[19]  S. Akira,et al.  Activation of TBK1 and IKKε Kinases by Vesicular Stomatitis Virus Infection and the Role of Viral Ribonucleoprotein in the Development of Interferon Antiviral Immunity , 2004, Journal of Virology.

[20]  F. Weber,et al.  NSs Protein of Rift Valley Fever Virus Blocks Interferon Production by Inhibiting Host Gene Transcription , 2004, Journal of Virology.

[21]  F. Weber,et al.  Inhibition of RNA Polymerase II Phosphorylation by a Viral Interferon Antagonist* , 2004, Journal of Biological Chemistry.

[22]  R. Elliott,et al.  A Bunyamwera Virus Minireplicon System in Mosquito Cells , 2004, Journal of Virology.

[23]  K. Magnusson,et al.  Human MxA Protein Inhibits the Replication of Crimean-Congo Hemorrhagic Fever Virus , 2004, Journal of Virology.

[24]  J. Egly,et al.  TFIIH Transcription Factor, a Target for the Rift Valley Hemorrhagic Fever Virus , 2004, Cell.

[25]  K. Mossman,et al.  Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication , 2004, Journal of Virology.

[26]  Å. Lundkvist,et al.  Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells , 2004, Journal of medical virology.

[27]  Daniel R. Caffrey,et al.  LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.

[28]  H. Klenk,et al.  The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.

[29]  Stanley M. Lemon,et al.  Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease , 2003, Science.

[30]  Guo-Ping Zhou,et al.  Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.

[31]  Nicole M. Bouvier,et al.  Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins , 2003, Journal of Virology.

[32]  F. Weber,et al.  Bunyamwera Bunyavirus Nonstructural Protein NSs Counteracts the Induction of Alpha/Beta Interferon , 2002, Journal of Virology.

[33]  C. Biron,et al.  Promotion of Alpha/Beta Interferon Induction during In Vivo Viral Infection through Alpha/Beta Interferon Receptor/STAT1 System-Dependent and -Independent Pathways , 2002, Journal of Virology.

[34]  A. Harman,et al.  Activation of Interferon Response Factor-3 in Human Cells Infected with Herpes Simplex Virus Type 1 or Human Cytomegalovirus , 2001, Journal of Virology.

[35]  C. Samuel,et al.  Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.

[36]  D. Levy,et al.  IRF3 and IRF7 Phosphorylation in Virus-infected Cells Does Not Require Double-stranded RNA-dependent Protein Kinase R or IκB Kinase but Is Blocked by Vaccinia Virus E3L Protein* , 2001, The Journal of Biological Chemistry.

[37]  Amer A. Beg,et al.  Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.

[38]  A. García-Sastre,et al.  Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein , 2000, Journal of Virology.

[39]  G. Sen,et al.  Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection. , 2000, Virology.

[40]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[41]  M. David,et al.  Cytomegalovirus Activates Interferon Immediate-Early Response Gene Expression and an Interferon Regulatory Factor 3-Containing Interferon-Stimulated Response Element-Binding Complex , 1998, Molecular and Cellular Biology.

[42]  M. Vidal,et al.  Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. , 1998, Genes & development.

[43]  T. Maniatis,et al.  Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. , 1998, Molecular cell.

[44]  J. Kusari,et al.  Regulation of synthesis and turnover of an interferon-inducible mRNA , 1986, Molecular and cellular biology.

[45]  J. Howie.  Significance of Escherichia coli in cheese. , 1981, Lancet.

[46]  D. Simpson,et al.  CONGO/CRIMEAN HÆMORRHAGIC FEVER IN DUBAI An Outbreak at the Rashid Hospital , 1980, The Lancet.

[47]  A. Ghafoor,et al.  Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976. , 1980, The American journal of tropical medicine and hygiene.

[48]  A. Shepherd,et al.  Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. , 1987, The American journal of tropical medicine and hygiene.